Scope

Although mathematics and physics have a long history of interaction, interdisciplinary projects where mathematics interacts with biology and medicine have only become a hot topic in the last decades. To foster such interactions, we offer young researchers to meet each other during a conference highlighting the interplay between oncology, mathematics and numerics: the IBOMAN conference is an opportunity to give the floor to young people involved in interdisciplinary projects related to cancer research, whether fundamental or applied.

This 2021 edition will focus on the topic of treatment, with sessions related to identifying new therapeutic targets or predicting the effect of a treatment. In addition to the talks of young researchers, a master class will be scheduled, as well as talks given by senior researchers who sponsor the conference. To complete the program, a step-aside talk will be provided, in order to stimulate more general discussions around science.

Notes :

  • deadline for registration is october 4th
  • all time slots for oral presentations are fulfilled, but...

Call for posters! Feel free to propose a poster using the abstract submission tab. Posters will be widely accepted, provided the main topic revolves around cancers. Please note that accomodation and travel expenses for researchers presenting a poster will not be covered by the conference.

 

Speakers

Plenary speakers

Masterlass

  • Alexandre Harlé (Université de Lorraine, Nancy)

Philosophy of Biology

Meet the industry

  • Adèle L'Hostis (Novadiscovery, Lyon)

Invited speakers

Location

The conference will take place at Institut Curie, 12 rue Lhomond, 75005 PARIS

Registration

The registration for the conference is free of charge but mandatory (NB: deadline for registration 4 october)

Organizers

  • Julie Dardare, Ph.D. student at the Institut de Cancérologie de Lorraine (Nancy).
  • Ulysse Herbach, scientific researcher at Inria (Nancy).
  • Emma Leschiera, Ph.D. student at the Jacques-Louis Lions laboratory, Sorbonne Université (Paris).
  • Hugo Martin, postdoctoral fellow, Inserm, Institut Curie (Paris).
  • Angélique Perrillat-Mercerot, research fellow at Novadiscovery (Lyon).
  • Alexandre Poulain, postdoctoral fellow, Simula research laboratory (Oslo, Norway).
  • Andréa Witz, Ph.D. student at the Institut de Cancérologie de Lorraine (Nancy)

Sponsors

image_logos_iboman.png

Online user: 2